My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy
Manoja K. Brahma (Brahma MK), Mark E. Pepin (Pepin ME), Adam R. Wende (Wende AR)
Diabetes Metab J. 2017;41(1):1-9.   Published online 2016 Nov 15     DOI: https://doi.org/10.4093/dmj.2017.41.1.1
Citations to this article as recorded by Crossref logo
High Throughput Screen Identifies Small Molecule Effectors That Modulate Thin Filament Activation in Cardiac Muscle
Priyanka Parijat, Laszlo Kondacs, Alexander Alexandrovich, Mathias Gautel, Alexander J. A. Cobb, Thomas Kampourakis
ACS Chemical Biology.2021; 16(1): 225.     CrossRef
Prostaglandin E receptor subtype 4 protects against diabetic cardiomyopathy by modulating cardiac fatty acid metabolism via FOXO1/CD36 signalling
Fan Ying, Hao Liu, Eva Hoi Ching Tang, Ishan Lakhani, Ningning Liu, Zhengyuan Xia, Shiming Liu
Biochemical and Biophysical Research Communications.2021; 548: 196.     CrossRef
Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage
Masayoshi Takeuchi, Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama, Chigusa Kikuchi, Ayako Furukawa, Kentaro Nagamine, Takamitsu Hori, Tamihide Matsunaga
Biomolecules.2021; 11(3): 387.     CrossRef
Phosphorylated and O-GlcNAc Modified IRS-1 (Ser1101) and -2 (Ser1149) Contribute to Human Diabetes Type II
Afshan Kaleem, Sabahat Javed, Nayab Rehman, Roheena Abdullah, Mehwish Iqtedar, Mohammad Nauman Aftab, Daniel C. Hoessli, Ikram-Ul Haq
Protein & Peptide Letters.2021; 28(3): 333.     CrossRef
Diabetes and Heart Failure: Multi-Omics Approaches
Akram Tayanloo-Beik, Peyvand Parhizkar Roudsari, Mostafa Rezaei-Tavirani, Mahmood Biglar, Ozra Tabatabaei-Malazy, Babak Arjmand, Bagher Larijani
Frontiers in Physiology.2021;[Epub]     CrossRef
Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes
Ana Maria Stanton, Muthiah Vaduganathan, Lee-Shing Chang, Alexander Turchin, James L. Januzzi, Vanita R. Aroda
Current Diabetes Reports.2021;[Epub]     CrossRef
Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization
Manoja K. Brahma, Chae‐Myeong Ha, Mark E. Pepin, Sobuj Mia, Zhihuan Sun, John C. Chatham, Kirk M. Habegger, Evan Dale Abel, Andrew J. Paterson, Martin E. Young, Adam R. Wende
Journal of the American Heart Association.2020;[Epub]     CrossRef
Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes
Darnel Prakoso, Miles J. De Blasio, Mitchel Tate, Helen Kiriazis, Daniel G. Donner, Hongwei Qian, David Nash, Minh Deo, Kate L. Weeks, Laura J. Parry, Paul Gregorevic, Julie R. McMullen, Rebecca Helen Ritchie
American Journal of Physiology-Heart and Circulatory Physiology.2020; 318(4): H840.     CrossRef
The Potential Role of MicroRNA in Diabetic Cardiomyopathy
Jin Hwa Kim
Diabetes & Metabolism Journal.2020; 44(1): 54.     CrossRef
Re-balancing cellular energy substrate metabolism to mend the failing heart
Jan F.C. Glatz, Miranda Nabben, Martin E. Young, P. Christian Schulze, Heinrich Taegtmeyer, Joost J.F.P. Luiken
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(5): 165579.     CrossRef
The Peroxisome Proliferator-Activated Receptor-Gamma Coactivator-1α–Heme Oxygenase 1 Axis, a Powerful Antioxidative Pathway with Potential to Attenuate Diabetic Cardiomyopathy
Maayan Waldman, Michael Arad, Nader G. Abraham, Edith Hochhauser
Antioxidants & Redox Signaling.2020; 32(17): 1273.     CrossRef
miR‑155 modulates high glucose‑induced cardiac fibrosis via the Nrf2/HO‑1 signaling pathway
Yu Li, Jing‑Zhu Duan, Qian He, Chong‑Quan Wang
Molecular Medicine Reports.2020;[Epub]     CrossRef
Disruption of energy utilization in diabetic cardiomyopathy; a mini review
Shinsuke Nirengi, Carmem Peres Valgas da Silva, Kristin I Stanford
Current Opinion in Pharmacology.2020; 54: 82.     CrossRef
The role of CD36 in cardiovascular disease
Hongyang Shu, Yizhong Peng, Weijian Hang, Jiali Nie, Ning Zhou, Dao Wen Wang
Cardiovascular Research.2020;[Epub]     CrossRef
Reduced fatty acid uptake aggravates cardiac contractile dysfunction in streptozotocin-induced diabetic cardiomyopathy
Yogi Umbarawan, Ryo Kawakami, Mas Rizky A. A. Syamsunarno, Norimichi Koitabashi, Hideru Obinata, Aiko Yamaguchi, Hirofumi Hanaoka, Takako Hishiki, Noriyo Hayakawa, Hiroaki Sunaga, Hiroki Matsui, Masahiko Kurabayashi, Tatsuya Iso
Scientific Reports.2020;[Epub]     CrossRef
Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort
Silvia M. Titan, Gabriela Venturini, Kallyandra Padilha, Alessandra C. Goulart, Paulo A. Lotufo, Isabela J. Bensenor, Jose E. Krieger, Ravi I. Thadhani, Eugene P. Rhee, Alexandre C. Pereira, Vivekanand Jha
PLOS ONE.2019; 14(3): e0213764.     CrossRef
Chronic hyperglycemia as a risk factor in implant therapy
Fawad Javed, Georgios E. Romanos
Periodontology 2000.2019; 81(1): 57.     CrossRef
Recent advances in the pathogenesis of microvascular complications in diabetes
Sungmi Park, Hyeon-Ji Kang, Jae-Han Jeon, Min-Ji Kim, In-Kyu Lee
Archives of Pharmacal Research.2019; 42(3): 252.     CrossRef
Nutrient regulation of signaling and transcription
Gerald W. Hart
Journal of Biological Chemistry.2019; 294(7): 2211.     CrossRef
Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
Takanobu Takata, Akiko Sakasai-Sakai, Tadashi Ueda, Masayoshi Takeuchi
Scientific Reports.2019;[Epub]     CrossRef
Effects of Exercise to Improve Cardiovascular Health
Kelsey Pinckard, Kedryn K. Baskin, Kristin I. Stanford
Frontiers in Cardiovascular Medicine.2019;[Epub]     CrossRef
A new hyperpolarized 13C ketone body probe reveals an increase in acetoacetate utilization in the diabetic rat heart
Desiree Abdurrachim, Chern Chiuh Woo, Xing Qi Teo, Wei Xin Chan, George K. Radda, Philip Teck Hock Lee
Scientific Reports.2019;[Epub]     CrossRef
Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose
Simon Ducheix, Jocelyne Magré, Bertrand Cariou, Xavier Prieur
Frontiers in Endocrinology.2018;[Epub]     CrossRef
Proteomics of the Rat Myocardium during Development of Type 2 Diabetes Mellitus Reveals Progressive Alterations in Major Metabolic Pathways
Anders Valdemar Edhager, Jonas Agerlund Povlsen, Bo Løfgren, Hans Erik Bøtker, Johan Palmfeldt
Journal of Proteome Research.2018; 17(7): 2521.     CrossRef
Protective effects of astaxanthin on diabetic cardiomyopathy in rats
Bingshan Zhang, Di Xu
CyTA - Journal of Food.2018; 16(1): 909.     CrossRef
Au cœur de la cardiomyopathie diabétique
Alexandre Lugat, Michael Joubert, Bertrand Cariou, Xavier Prieur
médecine/sciences.2018; 34(6-7): 563.     CrossRef
Redox imbalance stress in diabetes mellitus: Role of the polyol pathway
Liang-jun Yan
Animal Models and Experimental Medicine.2018; 1(1): 7.     CrossRef
Heart rate dynamics during cardio-pulmonary exercise testing are associated with glycemic control in individuals with type 1 diabetes
Othmar Moser, Max L. Eckstein, Olivia McCarthy, Rachel Deere, Stephen C. Bain, Hanne L. Haahr, Eric Zijlstra, Tim Heise, Richard M. Bracken, Petter Bjornstad
PLOS ONE.2018; 13(4): e0194750.     CrossRef
Resistance exercise improves cardiac function and mitochondrial efficiency in diabetic rat hearts
Tae Hee Ko, Jubert C. Marquez, Hyoung Kyu Kim, Seung Hun Jeong, SungRyul Lee, Jae Boum Youm, In Sung Song, Dae Yun Seo, Hye Jin Kim, Du Nam Won, Kyoung Im Cho, Mun Gi Choi, Byoung Doo Rhee, Kyung Soo Ko, Nari Kim, Jong Chul Won, Jin Han
Pflügers Archiv - European Journal of Physiology.2018; 470(2): 263.     CrossRef
Adriamycin-induced cardiomyopathy can serve as a model for diabetic cardiomyopathy – a hypothesis
Kaviyarasi Renu, V.G. Abilash, P.B. Tirupathi Pichiah, Thabassum Akthar Syeda, Sankarganesh Arunachalam
Asian Pacific Journal of Tropical Biomedicine.2017; 7(11): 1041.     CrossRef
Proteome profiling in the aorta and kidney of type 1 diabetic rats
Moustafa Al Hariri, Mohamad Elmedawar, Rui Zhu, Miran A. Jaffa, Jingfu Zhao, Parvin Mirzaei, Adnan Ahmed, Firas Kobeissy, Fuad N. Ziyadeh, Yehia Mechref, Ayad A. Jaffa, Michael Bader
PLOS ONE.2017; 12(11): e0187752.     CrossRef